In this rapid fire discussion, Drs Rossing and Agarwal discuss the emerging role of mineralocorticoid receptor antagonists in CKD in T2D.
Earn Credit / Learning Objectives & Disclosures
---
Full URLs:
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/920925?src=mkm_podcast_addon_920925
